Service planning in Europe would benefit from complete registration of NMSCs
All cases of BCC, a type of NMSC, should be reported for better treatment planning and preventative health promotion campaigns.
Diagnostics
Low rates of migraine diagnosis further hindered by COVID-19 pandemic
Despite having a significant impact on quality of life, less than half of people with...
Impact of underdiagnosis of plaque psoriasis in Black and Hispanic Americans
Underdiagnosed plaque psoriasis in Black and Hispanic Americans can severely impact their quality of life...
ACC 21: Mavacamten improves health status in symptomatic HCM
Results from the Phase III trial EXPLORE-HCM presented at the 70th annual American College of...
Entresto has moderate clinical benefit compared to Ramipril after acute MI
Results from the PARADISE-MI trial on Entresto (sacubitril/valstartan) were presented at the 70th annual American...
Arcutis presents topline Phase III roflumilast data at EADV spring 2021
Arcutis Biotherapeutics released data at EADV from its Phase III trials about the efficacy of roflumilast, which will be Arcutis’ first agent to market, for PsO.
Alzheimer’s disease prevalence variation between Spain, the US and Japan
The global burden of dementia is rising. Worldwide, approximately 50 million individuals have dementia, of which Alzheimer's is most common, and there are nearly 10 million new cases each year, according to the World Health...
AD/PD 2021: routine adoption of biomarkers in clinical practice could improve diagnosis in Alzheimer’s disease
At this month's virtual 15th International Conference on Alzheimer’s Disease and Parkinson’s Disease (AD/PD 2021), Switzerland-based pharmaceutical company Roche presented the global challenges in the management of Alzheimer’s disease and discussed the lessons from the...
T1Detect screening could have lasting effects on T1D awareness and management
The Juvenile Diabetes Research Foundation (JDRF) have announced the launch of their groundbreaking screening initiative for type 1 diabetes (T1D), which aims to make early detection of T1D easier and more accessible to the broader...
Medidata and Project ALS partner to develop new therapeutic strategies
Medidata, a subsidiary of Dassault Systèmes, and Project ALS have entered a research partnership in order to develop new therapeutic strategies for the treatment of Amyotrophic lateral sclerosis (ALS).
August’s top news stories
Biopharmaceutical firm Retrophin reported that the Phase III clinical trial of fosmetpantotenate failed to meet endpoints in pantothenate kinase-associated neurodegeneration (PKAN) patients; and MyoKardia has commenced dosing of patients in a Phase I trial of...
